Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor. [PDF]
The urotensin receptor (UT receptor), a G-protein-coupled receptor mediating urotensin-II and urotensin-II-related peptide signaling in the urotensinergic system, has multiple pharmacological activities.
Li N +9 more
europepmc +3 more sources
Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening. [PDF]
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an innate immune pattern recognition receptor responsible for the recognition of bacterial peptidoglycan fragments. Given its central role in the formation of innate and adaptive immune responses, NOD2 represents a valuable target for modulation with agonists and antagonists.
Guzelj S, Tomašič T, Jakopin Ž.
europepmc +6 more sources
Cosolvent-Based Protein Pharmacophore for Ligand Enrichment in Virtual Screening [PDF]
Virtual screening of large compound databases, looking for potential ligands of a target protein, is a major tool in computer-aided drug discovery. Throughout the years, different techniques such as similarity searching, pharmacophore matching, or molecular docking have been applied with the aim of finding hit compounds showing appreciable affinity ...
Juan Pablo Arcon +7 more
core +7 more sources
Combining docking with pharmacophore filtering for improved virtual screening [PDF]
Background Virtual screening is used to distinguish potential leads from inactive compounds in a database of chemical samples. One method for accomplishing this is by docking compounds into the structure of a receptor binding site in order to rank-order ...
Nicklaus Marc C, Peach Megan L
core +3 more sources
Can Chen,1,2,* Ting Wang,1,3,* Fengbo Wu,1,* Wei Huang,4 Gu He,1 Liang Ouyang,1 Mingli Xiang,1 Cheng Peng,4 Qinglin Jiang1,2 1State Key Laboratory of Biotherapy and Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 2College of ...
Huang W +8 more
core +1 more source
Development and validation of a 3D similarity method for virtual screening [PDF]
A predictive 3D similarity workflow approach has been developed using a set of modular Java computer programs that implement algorithms that aim to capture the key components of a 3D similarity search and aim to incorporate methods that address both ...
Butler, Daniel
core +6 more sources
Pharmacophore-Based Virtual Screening for Identification of Adenosine Deaminase Inhibitors. [PDF]
Background: Adenosine deaminase (ADA) is a key enzyme in purine metabolism, and abnormal ADA activity has been associated with various diseases, including severe combined immunodeficiency, cancer, neurodegenerative disorders, and liver diseases. Objectives: This study employed a pharmacophore-based virtual screening strategy to identify novel ADA ...
Ahmadi S +5 more
europepmc +3 more sources
Identification of BACE-1 Inhibitors against Alzheimer's Disease through E-Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation Studies: An Insilco Approach. [PDF]
Alzheimer is a severe memory and cognitive impairment neurodegenerative disease that is the most common cause of dementia worldwide and characterized by the pathological accumulation of tau protein and amyloid-beta peptides.
Chidambaram K.
europepmc +2 more sources
Pharmacophore-Based Virtual Screening of Novel GSTP1-1 Inhibitors
Glutathione transferase enzymes play an important role in metabolism and detoxification of numerous xenobiotics, electrophilic drugs, environmental carcinogens, and products of oxidative stress in living organisms. Human GST P1-1 is the most prevalent isoform of the mammalian cytosolic GSTs and this enzyme participates in a particular role in one of ...
Kayhan BOLELLİ, Tugba ERTAN-BOLELLİ
openaire +5 more sources
Autotaxin (ATX) is considered as an interesting drug target for the therapy of several diseases. The goal of the research was to detect new ATX inhibitors which have novel scaffolds by using virtual screening.
Ji-Xia Ren, Rui-Tao Zhang, Hui Zhang
doaj +1 more source

